Where does GigaGen, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GigaGen, Inc. ranks #14,006 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does GigaGen, Inc. hold?

GigaGen, Inc. holds 21 US utility patents granted between 2016 and 2025, spanning 7 technology areas.

What is GigaGen, Inc.'s Innovation Score?

GigaGen, Inc. has an Innovation Score of 32.8 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does GigaGen, Inc. focus on?

GigaGen, Inc.'s top technology area is C07K (Peptides) with 21 patents. Grants appear in 7 CPC subclasses total.

Is GigaGen, Inc.'s patent grant rate increasing or decreasing?

GigaGen, Inc.'s recent grant velocity is +43% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for GigaGen, Inc.'s patents?

GigaGen, Inc.'s patents average 11.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the GigaGen, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

GigaGen, Inc.

USPTO PatentsView assignee record - 21 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gigagen ranks #14,006 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 7 technology areas.

#14,006
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.8/100): 11.7
avg claims per patent: +43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14006 · US Corporation #14,006 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #14,006/49,997
PHOTO-FINISH Galiant Arts
CPC-NARROW C07K · 7 areas
INNOV-THIN 32.8/100
CLAIMS-PAR 11.7 claims/avg
TYPE-USCORP US Corporation
VEL-UP +43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Galiant Arts, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
GigaGen · this assignee

33
3D Lighting… · lowest

7

What this shows Gigagen's Innovation Score is 32.8/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Gigagen's grants concentrate

GigaGen, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2016. By volume, Gigagen sits between Guerlain and GrayMatter Robotics Inc..

Gigagen's three-year grant acceleration

GigaGen, Inc. shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Guerlain

21
Galiant Arts

21
Gallagher Group

21
Gary Platt Manufa…

21
Ginger io

21
Glance Networks

21
Gopod Group

21
Graymatter Roboti…

21
Gigagen ◀

21

What this shows GigaGen holds 21 patents at rank #14,015, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GigaGen

By rank, the assignees closest to #14,015 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in GigaGen's primary technology class.

Gigagen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

GigaGen, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	4.8%
2017	2	9.5%
2018	1	4.8%
2019	3	14.3%
2020	2	9.5%
2021	2	9.5%
2022	2	9.5%
2023	4	19.0%
2025partial year	4	19.0%

Which technologies does GigaGen, Inc. patent most?

C07K - Peptides 21

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 19

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 19

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 17

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

Y02A - Technologies FOR Adaptation TO Climate Change 3

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#14,006

of 49,997 tracked assignees

Innovation Score

32.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

GigaGen, Inc.'s patent record in context - here's where to go next.

GigaGen, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #14,006 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GigaGen, Inc. against Guerlain, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.